Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94


Adolescent providers' knowledge of human papillomavirus vaccination age guidelines in five countries.

Topazian HM, Dizon AM, Di Bona VL, Levitz L, Ramos S, Morgan K, Kim CJ, Richter K, De Sanjose S, Smith JS.

Hum Vaccin Immunother. 2019 Jan 9:1-6. doi: 10.1080/21645515.2018.1558688. [Epub ahead of print]


HPV Vaccination Recommendation Practices among Adolescent Health Care Providers in 5 Countries.

Topazian HM, Kundu D, Peebles K, Ramos S, Morgan K, Kim CJ, Richter KL, Brewer NT, Peris M, Smith JS.

J Pediatr Adolesc Gynecol. 2018 Dec;31(6):575-582.e2. doi: 10.1016/j.jpag.2018.06.010. Epub 2018 Jul 12.


Acceptability of two- versus three-dose human papillomavirus vaccination schedule among providers and mothers of adolescent girls: a mixed-methods study in five countries.

Islam JY, Hoyt AM, Ramos S, Morgan K, Kim CJ, de Sanjose S, Butera N, Senkomago V, Richter KL, McDonald MA, Vielot NA, Smith JS.

Cancer Causes Control. 2018 Nov;29(11):1115-1130. doi: 10.1007/s10552-018-1085-1. Epub 2018 Oct 4.


Acceptability of multipurpose human papillomavirus vaccines among providers and mothers of adolescent girls: A mixed-methods study in five countries.

Vielot NA, Goldberg SK, Zimet G, Smith SB, Anne McDonald M, Ramos S, Morgan K, Joo Kim C, Richter KL, Peris M, Whaley KJ, Smith JS.

Papillomavirus Res. 2017 Jun;3:126-133. doi: 10.1016/j.pvr.2017.04.001. Epub 2017 Apr 6.


Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012.

Berkowitz Z, Malone M, Rodriguez J, Saraiya M.

Prev Med. 2015 Dec;81:405-11. doi: 10.1016/j.ypmed.2015.10.007. Epub 2015 Oct 24.


Persuasive messaging for human papillomavirus vaccination by adolescent providers in a five-country multi-site study.

Rwamwejo J, Ramos S, Morgan K, Richter K, Kim CJ, Peris M, Smith JS.

Int J Gynecol Cancer. 2019 Feb;29(2):250-256. doi: 10.1136/ijgc-2018-000004. Epub 2019 Jan 4.


Health Care Providers' Knowledge of HPV Vaccination, Barriers, and Strategies in a State With Low HPV Vaccine Receipt: Mixed-Methods Study.

Warner EL, Ding Q, Pappas L, Bodson J, Fowler B, Mooney R, Kirchhoff AC, Kepka D.

JMIR Cancer. 2017 Aug 11;3(2):e12. doi: 10.2196/cancer.7345.


A model of health care provider decision making about HPV vaccination in adolescent males.

Alexander AB, Best C, Stupiansky N, Zimet GD.

Vaccine. 2015 Aug 7;33(33):4081-6. doi: 10.1016/j.vaccine.2015.06.085. Epub 2015 Jul 2.


Primary care providers human papillomavirus vaccine recommendations for the medically underserved: a pilot study in U.S. Federally Qualified Health Centers.

Roland KB, Benard VB, Greek A, Hawkins NA, Saraiya M.

Vaccine. 2014 Sep 22;32(42):5432-5. doi: 10.1016/j.vaccine.2014.07.098. Epub 2014 Aug 12.


Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey.

Ylitalo KR, Lee H, Mehta NK.

Am J Public Health. 2013 Jan;103(1):164-9. doi: 10.2105/AJPH.2011.300600. Epub 2012 Jun 14.


Parent perceptions of dentists' role in HPV vaccination.

Lazalde GE, Gilkey MB, Kornides ML, McRee AL.

Vaccine. 2018 Jan 25;36(4):461-466. doi: 10.1016/j.vaccine.2017.12.020. Epub 2017 Dec 24.


"You're never really off time": Healthcare providers' interpretations of optimal timing for HPV vaccination.

Henrikson NB, Tuzzio L, Gilkey MB, McRee AL.

Prev Med Rep. 2016 May 16;4:94-7. doi: 10.1016/j.pmedr.2016.05.002. eCollection 2016 Dec.


Influential factors in HPV vaccination uptake among providers in four states.

McCave EL.

J Community Health. 2010 Dec;35(6):645-52. doi: 10.1007/s10900-010-9255-4.


Predictors of Human Papillomavirus Vaccination Among Young Men Who Have Sex With Men.

Gerend MA, Madkins K, Phillips G 2nd, Mustanski B.

Sex Transm Dis. 2016 Mar;43(3):185-91. doi: 10.1097/OLQ.0000000000000408.


Providers' practice, recommendations and beliefs about HPV vaccination and their adherence to guidelines about the use of HPV testing, 2007 to 2010.

Berkowitz Z, Nair N, Saraiya M.

Prev Med. 2016 Jun;87:128-131. doi: 10.1016/j.ypmed.2016.02.030. Epub 2016 Feb 26.


Missing the Target for Routine Human Papillomavirus Vaccination: Consistent and Strong Physician Recommendations Are Lacking for 11- to 12-Year-Old Males.

Vadaparampil ST, Malo TL, Sutton SK, Ali KN, Kahn JA, Casler A, Salmon D, Walkosz B, Roetzheim RG, Zimet GD, Giuliano AR.

Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1435-1446. Epub 2016 Aug 2.


Physicians' human papillomavirus vaccine recommendations in the context of permissive guidelines for male patients: a national study.

Malo TL, Giuliano AR, Kahn JA, Zimet GD, Lee JH, Zhao X, Vadaparampil ST.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2126-35. doi: 10.1158/1055-9965.EPI-14-0344. Epub 2014 Jul 15.


Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls.

Vadaparampil ST, Staras SA, Malo TL, Eddleton KZ, Christie J, Rodriguez M, Giuliano AR, Shenkman EA.

Cancer. 2013 Feb 1;119(3):621-8. doi: 10.1002/cncr.27735. Epub 2012 Aug 1.


Why is announcement training more effective than conversation training for introducing HPV vaccination? A theory-based investigation.

Malo TL, Hall ME, Brewer NT, Lathren CR, Gilkey MB.

Implement Sci. 2018 Apr 19;13(1):57. doi: 10.1186/s13012-018-0743-8.


Prevalence and predictors of human papillomavirus vaccination in adolescent girls.

Palli SR, Mehta S, Aparasu RR.

J Am Pharm Assoc (2003). 2012 Jan-Feb;52(1):52-8. doi: 10.1331/JAPhA.2012.10195.


Supplemental Content

Support Center